Photo by by NaturesCharm
Cannabis is often framed as a “green rush,” but the reality is closer to a regulated, capital-intensive consumer packaged goods business with unusually high operational friction. As a result, many founders fail before opening their doors. That’s not because the product is bad. It’s because the business is built on assumptions that collapse under licensing, compliance, banking constraints, and the basic economics of competing in a market where incumbents and well financed operators can outlast early mistakes.
Below are the most common pre-launch failure points, and what founders routinely underestimate.
1) They Treat Licensing Like Paperwork Instead of a Gating Strategy
In cannabis, a startup is not “real” until it is licensed, and the path to a license is rarely linear. Applications require precision, documented control structures, detailed operating plans, and extensive disclosures. Founders often build a brand, sign a lease, and hire staff before the regulatory timeline is clear. When the timeline slips, fixed costs keep accruing while the business cannot legally operate.
At December’s Cannabis Control Board (CCB) meeting, general manager of Rural Resurgence dispensary Brian Dewey said: “I’m spending over $300 a day on my business that isn’t open. Our location is fully built out. We are compliant. Our staff is ready. Our security inventory systems and procedures are in place. We are not asking for special treatment. We’re just asking for basic communication so we can move forward or correct whatever issue may exist.”
This is one example of the many situations where even after licenses are issued, regulators may require fingerprinting, “true party of interest” disclosures, updated site information, local approvals, and additional documentation to begin full operations. These are not administrative footnotes. They directly determine when revenue can begin and whether capital lasts long enough to reach opening day.
What to do instead: Similar to other highly regulated industries like Biotech, treat licensing as the core product in the first phase. Build work plans around regulatory milestones, not marketing milestones. Assume rework and delays, and structure burn rates accordingly.
2) They Sign Real Estate Too Early, or Choose the Wrong Real Estate
Real estate kills more cannabis startups than competition does. Leases are signed before approval, zoning is misunderstood, proximity rules are misread, and buildouts become hostage to permitting timelines. If a business model requires a specific location, a business may face a simple risk: the location may be unavailable, non compliant, or economically unsustainable once security requirements, renovations, and local restrictions are layered.
In Dewey’s comments to the CCB, he explained that there is a location discrepancy. “There’s another business that’s supposedly 2,000 feet from me. That business can never open. The city knows this. The city has told us over and over again that that place will never open. For two years it’s almost sat vacant. And now that’s the business that’s blocking me from being open. Right now it’s on paper they have a license, but that’s it.”
New York is one of the states that applies proximity rules that can shift based on policy interpretation or the date a location is submitted. That means founders can be technically compliant at one moment and exposed the next, especially if they are competing for scarce “viable” retail corridors.
What to do instead: Negotiate contingencies, termination rights, and staged obligations. If this is not possible, it is effectively financing for the landlord while waiting for permission to operate.
3) They Undercapitalize the Pre-Revenue Period
A standard startup can iterate toward product market fit while selling early. Cannabis cannot. The business must be built, compliant, and inspected before revenue. That creates a “dead zone” where spending is real but income is not.
Founders frequently budget for rent and renovations, then get blindsided by security vendors, POS compliance, inventory tracking systems, legal reviews, insurance, testing, staffing requirements, and licensing renewals. The problem compounds when delays extend from weeks to months. The business does not fail because it cannot be profitable. It fails because it cannot survive long enough to open.
What to do instead: Build a cash model with conservative timelines, contingency buffers, and explicit assumptions for regulatory delays. If the plan only works when everything goes right, it will not work.
4) They Misunderstand the Market Structure and Oversupply Dynamics
Cannabis markets are unstable. They move through cycles: oversupply and margin compression followed by limited supply and high prices. This is particularly true around Croptober, when newly harvested cannabis enters the market. Many founders base projections on early market pricing that will not persist.
For example, regulators in New York have discussed slowing cultivation approvals due to oversupply risk, noting prior surpluses that harmed product quality and encouraged diversion to unregulated markets. They also cited canopy capacity on the order of millions of square feet across cultivators and microbusinesses.
This matters to retailers and brands because oversupply can lower wholesale prices. But it also intensifies competition, widens assortment, and makes customer acquisition more expensive.
At the same time, demand and access can rise quickly as more stores open. New York’s market has reported hundreds of open dispensaries and significant sales growth, which attracts new entrants and increases competitive pressure.
What to do instead: Model multiple pricing environments. Assume wholesale and retail pricing will move against the business. Build a plan that survives compression, not just a plan that thrives in ideal conditions.
5) They Confuse Branding with Distribution
Many cannabis startups start as brand decks. Packaging, strain names, influencer strategies, and launch events are built first. But cannabis is a distribution constrained business. Without reliable supply, compliant packaging, testing throughput, and retail shelf access, the brand is an expense rather than an asset.
Even in markets where advertising rules are loosening, marketing is still bounded by compliance and operational reality. For instance, regulators may revise rules around promotions or signage. But those changes do not solve the underlying problem of shelf space and customer retention.
What to do instead: Start with a route to market. Secure supply agreements, define the retailer value proposition, and build a compliance ready packaging and labeling workflow before spending heavily on “launch” campaigns.
6) They Misjudge Compliance as a One-Time Hurdle
Compliance is an operating system. Seed-to-sale tracking, lab testing, packaging standards, advertising restrictions, security protocols, and recordkeeping requirements create an ongoing workload that must be staffed and audited internally.
Startups commonly fail pre launch because they try to run compliance with one overstretched generalist, or they outsource it without internal ownership. When an inspection, corrective action, or local complaint hits, they are forced into expensive remediation that delays opening.
What to do instead: Assign accountable ownership. Implement SOPs, training, and internal audits before opening. Budget for compliance headcount, not just compliance vendors.
Cannabis startups do not usually fail because founders lack passion. They fail because the business is treated like a typical startup when it is structurally different: permissioned, compliance heavy, and cash hungry before revenue begins. Founders who accept that reality early, and design around it, dramatically increase their chances of actually reaching launch day.
Leave a Reply